Business Context and Reporting Period
This Form 8-K Current Report is filed by Nephros, Inc., a Delaware corporation, with a reporting date of June 30, 2016. The filing addresses a corporate governance event regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure of personnel changes and does not contain financial statements or performance data.
Material Changes
The material change disclosed is the departure of a director:
- Resignation: Matthew D. Rosenberg resigned as a member of the Board of Directors, effective June 30, 2016.
- Reason: The resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies beyond the standard disclosure of the director's departure.
Investor Verification Checklist
- Verify the current composition of the Board of Directors following Mr. Rosenberg's resignation.
- Check for any subsequent filings regarding the appointment of a replacement director.
- Review the most recent 10-Q or 10-K for financial performance data, as this 8-K does not include it.